Fetal therapy: prospects for transplantation early in pregnancy. In utero stem cell transplantation and gene therapy: second international meeting, Nottingham, UK, 1-2 September 1997.
The meeting was punctuated by discussion sessions enabling delegates and speakers to debate issues raised. A number of questions were aired and areas that need to be addressed with some urgency were highlighted. Tolerance induction in utero is now considered feasible and can be added to the potential outcomes of IUT. Agreement must be reached on the source of stem cells for IUT, and stem cell banking will need to meet internationally accepted standards. Finally, the transplantation protocol itself must be agreed, a challenge that must be met if IUT is to join the mainstream of therapeutic protocols.
Jones
D R
DR
Dept of Immunology, Queen's Medical Centre, Nottingham, UK. d.r.e.jones@nottingham.ac.uk
Bui
T H
TH
D000818:Animals; D005260:Female; D005315:Fetal Diseases; D015316:Genetic Therapy / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D011247:Pregnancy; D014599:Uterus